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We studied a step where tyrosine phosphorylation is involved in a signaling pathway for the activation of the superoxide (O&generating NADPH 
oxidase using electropermeabilized human neutrophils. The permeabilized cells produced 0; by the addition of a protein tyrosine phosphatase 
inhibitor, vanadate, as well as N-formyl-methionyl-leucyl-phenylalanine (fMLP) and protein kinase C (PKC) activators uch as phorbol myristate 
acetate (PMA) and L-a-I-oleoyl-2-acetoyl-sn-3-glycerol (OAG). The 0; production by the stimulants was completely inhibited by PKC inhibitors 
such as calphostin C and staurosporine and was not affected by 1% ethanol, a metabolic modulator of phospholipase D (PLD). Furthermore, the 
0; production by vanadate and WLP, but not by OAG and PMA, was inhibited by both an inhibitor of phosphohpase C (PLC), neomycin, and 
an inhibitor of tyrosine kinase, ST-638. These findings suggest hat tyrosine phosphorylation is involved in the activation of the oxidase at a step 
before diacylglycerol formation by PLC, and that PLD may not be involved in the signaling pathway in permeabihzed cells. 
Human neutrophil; Respiratory burst; Electropermeabihzation; Signal transduction; Tyrosine phosphorylation; Phosphohpase C 
1. INTRODUCTION 
Neutrophils are important in the host defense against 
microbial infection [l] and for this purpose, are 
equipped with an enzymatic omplex, NADPH oxidase, 
which is able to catalyze the one-electron reduction of 
molecular oxygen to superoxide (0;). The oxidase is 
dormant in non-activated neutrophils and the signal 
transduction process leading to the activation of the 
oxidase has been extensively studied [2,3]. It is generally 
accepted that binding of agonists to their receptors tim- 
ulates phospholipase C (PLC) through the activation of 
a GTP-binding protein. The PLC hydrolyzes phosphat- 
idylinositol 4,5_bisphosphate into the calcium ion mo- 
bilizer, inositol 1,4,5trisphosphate, and the protein ki- 
nase C (PKC) activator, 1,2-diacylglycerol (DAG). The 
activation of PKC leads to the conversion of dormant 
oxidase into its active form in an unknown manner. 
Recently, it has been reported that tyrosine phosphoryl- 
ation is involved in the signaling pathway [4-131. Grin- 
stein et al. [I 1 J and Trudel et al. [12,13] have reported 
that neutrophils and granulocytic HL60 cells possess 
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constitutively active tyrosine kinases, and phosphopro- 
tein accumulation is normally prevented by vigorous 
concomitant protein tyrosine phosphatase activity, and 
that vanadate induces the accumulation of tyrosine- 
phosphorylated proteins by inhibiting the protein tyro- 
sine phosphatase activity with close correlation to the 
induction of the respiratory burst. N-Formyl- 
methionyl-leucyl-phenylalanine (fMLP) also induces ty- 
rosine phosphorylation on several proteins, and the in- 
cubation of neutrophils with tyrosine kinase inhibitors, 
such as ST-638 and erbstatin, decreases both the 
amount of tyrosine phosphorylation and 0; production 
induced by fMLP [5-91. The exact step affected by tyro- 
sine phosphorylation in the signaling pathway, how- 
ever, has not been identified. 
Permeabilized cells are useful for investigating the 
signaling pathway because they have pores on the 
plasma membrane through which agents with molecular 
weights below 1,000 Da permeate, and which produce 
0; on stimulation by vanadate, fMLP and PKC ac- 
tivators [l l-161. We have recently reported that cyclic 
AMP inhibits the respiratory burst at a site downstream 
of PKC [I 71. The present studies were undertaken to 
clarify the step of tyrosine phosphorylation in the sig- 
naling pathway for the respiratory burst. For this pur- 
pose, we examined the effects of inhibitors of PKC, PLC 
and tyrosine kinase on 0; production induced by vana- 
date, fMLP, and PKC activators such as phorbol myris- 
tate acetate (PMA) and L-a-1-oleoyl-2-acetoyl-sn-3- 
glycerol (OAG), using electropermeabilized human 
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neutrophils. We also studied the involvement of phos- 
pholipase D (PLD) in the signaling pathway of permea- 
bilized cells using ethanol, a metabolic modulator of 
PLD, because PLD has been reported to be involved in 
the pathway [18-241. The results suggest hat tyrosine 
phosphorylation occurs at a step before DAG forma- 
tion by PLC, and that PLD is not involved in the path- 
way for activating the respiratory burst of permeabil- 
ized cells. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Staurosporine and calphostin C were purchased from Kyowa 
Medex, Tokyo, Japan. NADPH and ATP were from Oriental Yeast, 
Tokyo, Japan. OAG was from Funakoshi Chemical, Tokyo, Japan. 
SDS was from Wako Pure Chemical Industries, Osaka, Japan. The 
following materials were obtained from Sigma Chemical Co., St. 
Louis, MO, USA: L-a-phosphatidylinositol 4,5-bisphosphate (PIPI), 
ferricytochrome c, superoxide dismutase (SOD), PMA, fMLP, neomy- 
cin sulfate and sodium orthovanadate. a-Cyano-3-ethoxy-4-hydroxy- 
5-phenylthiomethylcinnamamide (ST-638) was generously given by 
Kanegafuchi Chemical Industry, Tokyo, Japan. All other reagents 
were of analytical grade. 
2.2. Preparation of human neutrophils 
Human neutrophils were isolated from a healthy donor as described 
previously [25]. In short, after elimination of erythrocytes by dextran 
sedimentation followed by a brief hypotonic lysis, the cell suspension 
was centrifuged in a Ficoll-sodium iothalamate gradient to separate 
the polymorphonuclear leukocytes from lymphocytes, monocytes and 
platelets. Isolated cells were suspended in a HEPES-buffered salt solu- 
tion containing 135 mM NaCl, 5 mM KCI, 5 mM glucose and 20 mM 
HEPES (pH 7.4) and stored on ice until use. For electropermeabiliza- 
tion, cells were suspended in an ice-cold permeabilization medium 
containing 140 mM KCI, I mM MgCl,, 1 mM EGTA, 0.193 mM 
CaCI,, 10 mM glucose and IO mM HEPES (pH 6.7). 
2.3. Cell permeabilization 
Permeabilization was performed according to the method of Lu and 
Grinstein [16] except that the ice-cold permeabilization medium was 
adjusted to pH 6.7 (4°C). Briefly, 8 x lo6 cells were transfered to a 
Bio-Rad Gene Pulser and permeabilized with two discharges of 5 
kV/cm from a 25-microfarad capacitor. Between pulses, cells were 
rapidly sedimented and resuspended in the fresh ice-cold medium. 
Permeabilized cells were sedimented and finally suspended in an assay 
buffer containing 140 mM KCl, 1 mM MgCl?, 1 mM EGTA, 0.193 
mM CaCl,, IO mM glucose and 1OmM HEPES (pH 6.7 at 37°C). Cells 
(2 x 106) were used for each assay within I5 min of preparation. 
2.4. Acetylation offerricytochrome c 
Ferricytochrome c was acetylated as previously described [26]. At 
4°C 200 mg of ferricytochrome c was dissolved in 10 ml of a half- 
saturated solution of sodium acetate. After 0.4 ml of acetic anhydride 
was added and stirred for 30 min, the reaction mixture was dialyzed 
at 4°C for 12 h against the assay buffer. 
2.5. Assay of the 0; production by intact neutrophils 
The assay mixture (1.0 ml) consisted of 50 PM ferricytochrome c, 
1 mM CaCI, and 1 x lo6 cells in the HEPES-buffered salt solution (see 
section 2.2). Cells were incubated at 37°C for 5 min and 0; production 
was initiated by the addition of a stimulant and measured by determin- 
ing the rate of superoxide dismutase (SOD)-inhibitable ferricyto- 
chrome c reduction at 550-540 nm using a dual-wavelength spectro- 
photometer (Hitachi 556) as previously described [25]. The 0; release 
was calculated using a molar absorption coefficient of 19,100 
Mm’ cm-‘. 
2.6. Assay of the 0; production by electropermeabilized neutrophils 
The assay mixture (1.0 ml) consisted of 50 PM acetylated cyto- 
chrome c and 2 x lo6 cells in the assay buffer (see section 2.3). Under 
this condition, the Car’ concentration in the reaction mixture was 
about 100 nM [15]. Cells were incubated at 37°C for 5 min followed 
by the addition of 2 mM NADPH and 1 mM ATP. The production 
of 0; was initiated by the addition of a stimulant and measured by 
determining the rate of SOD-inhibitable reduction of acetylated cyto- 
chrome c at 550-540 nm using a dual-wavelength spectrophotometer 
(Hitachi 556). The 0; release was calculated using a molar absorption 
coefficient of 19,100 M-’ cm-‘. 
3. RESULTS 
3.1. Effects of PKC inhibitors on the 0; production 
To investigate the step of tyrosine phosphorylation in 
the signaling pathway for activating NADPH oxidase, 
we examined the effects of PKC inhibitors on the 0; 
production of electropermeabilized human neutrophils 
induced by a protein tyrosine phosphatase inhibitor, 
vanadate, and other agents such as fMLP, OAG and 
PMA. The 0; production by the stimulants was dose- 
dependently inhibited by PKC inhibitors such as cal- 
phostin C and staurosporine, and the production was 
completely abolished by 5 PM calphostin C (Table I) 
and 10 nM staurosporine (results not shown). In the 
present study, we used calphostin C and staurosporine 
as PKC inhibitors because it had been reported that 
they inhibit PKC by different mechanisms and that cal- 
phostin C is a relatively specific inhibitor for PKC, 
although staurosporine may also inhibit other protein 
kinases [27-291. The NADPH oxidase activity itself was 
not affected by the inhibitors because the 0; production 
of permeabilized cells by SDS was inhibited by neither 
5 PM calphostin C nor 10 nM staurosporine [ 171. These 
results suggest hat the signal transduction process lead- 
Table I 
Effects of ethanol and calphostin C on 0; production of permeabilized 
neutrophils 
Stimulants Pretreatments 
Calphostin C Calphostin C Ethanol (1%) 
(2 PM) (5 PM) 
(% of control) (% of control) (% of control) 
fMLP 
Vanadate 
OAG 
PMA 
9.3 * 6.6 0.0 f 0.0 94.1 + 4.3 
16.7 + 6.2 0.0 * 0.0 91.4 + 0.7 
42.3 f 5.0 0.0 f 0.0 95.0 ?r 4.3 
37.3 + 7.6 0.0 f 0.0 94.6 ? 4.0 
Permeabilized neutrophils (2 x 106/ml) were preincubated with etha- 
nol and calphostin C for I min and 5 min, respectively, at 37°C and 
then stimulated by 1 PM f?vlLP, 10 PM vanadate, 10 PM OAG or 10 
@ml PMA. The 0; production was measured as described in section 
2. The activities are given as the percentages of control activities. The 
control activities of permeabilized cells by fMLP, vanadate, OAG and 
PMA were 0.93 + 0.08, I .39 & 0.06,2.55 f 0.05 and 2.80 ? 0.19 nmol/ 
min/106 cells, respectively. The data represent he means + S.D. of 
three separate xperiments. 
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Fig. 1. Effect of neomycin on 0; production by various stimulants in 
permeabilized neutrophils. The 0; production was measured as de- 
scribed in section 2 except that neomycin at various concentrations 
was added to the assay mixture 1 min before the addition of a stimu- 
lant. The results are representative ofat least three independent exper- 
iments. The activities are given as the percentages of control activities. 
The control activities of the 0; production by 1 ,uM MLP (A), 10,~M 
OAG (x), 10 @ml PMA (0) and 1OpM vanadate (A) were 0.76, 1.70, 
1.70 and 1.78 nmol/min/106 cells, respectively. 
ing to the respiratory burst induced by vanadate, fMLP, 
OAG and PMA is completely dependent on PKC, and 
that the step of tyrosine phosphorylation responsible 
for the 0; production induced by vanadate is located 
upstream of PKC. As shown in Table I, 2 ,uM of cal- 
phostin C more strongly inhibited the fMLP- and vana- 
date-induced 0, production than the PMA- and OAG- 
induced production. This may be due to the fact that 
calphostin C acts on the regulatory domain of PKC and 
the concentration of PMA or OAG might be higher 
than that of the diacylglycerol produced on stimulation 
by fMLP or vanadate, whereas staurosporine inhibited 
the 0; production induced by fMLP, vanadate, PMA 
Table II 
Effects of phosphatidylinositol 4,5-bisphosphate on the neomycin- 
inhibited 0; production of permeabilized neutrophils 
Condition Stimulants (% of control) 
fMLP Vanadate 
+ neomycin 24.0 + 3.6 24.0 f 3.7 
+ 1oflg PIP, 105.3 + 2.1 93.0 f 5.0 
+ neomycin + 5 pg PIP, 51.3 + 9.0 47.3 f 6.3 
+ neomycin + 10 pg PIP, 85.7 f 5.4 74.0 + 2.9 
The 0; production was measured as described in section 2. The perme- 
abilized neutrophils (2 x 106/ml) were preincubated with either 150 
PM neomycin for 1 min or phosphatidylinositol 4,5-bisphosphate 
(PIP,) for 5 min or both at 37°C and then stimulated by 1 PM lMLP 
or 10 ,uM vanadate. The activities are given as the percentages of 
control activities. The control activities of permeabilized cells by 
fMLP and vanadate were 1.05 f 0.14 and 1.63 f 0.35 nmoYmin/106 
cells, respectively. The data represent the means ? S.D. of three sepa- 
rate experiments. 
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and OAG in similar dose-dependent manners, probably 
by its action on the catalytic domain of PKC (results not 
shown). 
3.2. Effects of neomycin and ethanol on the 0; produc- 
tion 
The effect of an inhibitor of PLC, neomycin, on the 
0; production by permeabilized cells was examined to 
further investigate the step where tyrosine phosphoryla- 
tion responsible for 0; production induced by vanadate 
occurs in the signaling pathway. As shown in Fig. 1, 
neomycin inhibited the production by vanadate and 
fMLP in a similar dose-dependent manner, and 200 PM 
neomycin completely inhibited the production but only 
slightly inhibited the production of OAG and PMA. 
These results suggest hat the step of tyrosine phospho- 
rylation is upstream of the DAG formation by PLC. 
Although neomycin inhibits PLC by binding its sub- 
strates, inositol phospholipids, and has been used to 
show the involvement of PLC in various cellular re- 
sponses [30,31], it also affects other components of sig- 
nal transduction systems at high concentrations [32-341. 
In the present study, however, the inhibition by neomy- 
cin seems to be due to the inhibition of phosphoinositide 
breakdown by PLC because the concentration of neo- 
mycin used was low enough and the inhibition by neo- 
mycin was remarkably restored by the addition of 10 pug 
PIP, (Table II). 
We also investigated whether phospholipase D (PLD) 
is involved in the signaling pathway for the respiratory 
burst of permeabilized cells because DAG may be gen- 
erated not only by PLC but by PLD. In the presence of 
ethanol, the activation of PLD results in the formation 
of phosphatidylethanol through a transphosphatidyla- 
tion reaction, together with a decrease in phosphatidic 
acid (PA) generation. It has been reported that 1% eth- 
anol severely inhibits the 0; production mediated by 
PLD but not by phosphatidylinositol-specific PLC (PI- 
PLC) [21]. As shown in Table I, 1% ethanol hardly 
inhibited the 0, production of permeabilized cells by 
vanadate, fMLP, OAG and PMA, indicating that PLD 
seems not to be involved in the respiratory burst of the 
permeabilized cells under our experimental conditions. 
3.3. Effect of ST-438 on the 0; production 
Tyrosine phosphorylation has been supposed to be 
essential for the activation of the oxidase induced by 
fMLP in intact cells [5-91, which is partially based on 
the studies using tyrosine kinase inhibitors such as ST- 
638 and erbstatin. We ascertained whether tyrosine 
phosphorylation might be essential for 0; production 
of permeabilized cells as well as NLP-induced produc- 
tion in intact cells. As shown in Fig. 2, ST-638 dose- 
dependently inhibited 0; production not only by vana- 
date but by fMLP, and 15 PM ST-638 completely inhib- 
ited the production, whereas 15 PM ST-638 inhibited 
the production by OAG and PMA by only about 20% 
Volume 322, number 3 FEBSLETTERS May 1993 
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Fig. 2. Effect of ST-638 on 0; production by various stimulants in 
permeabilized neutrophils. The 0; production was measured as de- 
scribed in Fig. 1 except that ST-638 at various concentrations was 
added to the assay mixture 1 min before the addition of a stimulant. 
The results are representative of at least three independent experi- 
ments. The activities are given as the percentages of control activities. 
The control activities by fMLP (A), OAG (x), PMA (0) and vanadate 
(A) were 0.72, 2.22, 2.22 and 2.01 nmol/min/106 cells, respectively. 
(Fig. 2) indicating that tyrosine phosphorylation in- 
duced by fMLP, as well as by vanadate, was essential 
and occurs a step before DAG formation. These results 
support our hypothesis that tyrosine phosphorylation is 
involved in the signaling pathway for the respiratory 
burst at a step before DAG formation by PLC. 
4. DISCUSSION 
In the present study, we focused on a step where 
tyrosine phosphorylation is involved in the signaling 
pathway for the activation of the NADPH oxidase 
using electropermeabilized human neutrophils. The re- 
sults suggest hat tyrosine phosphorylation is necessary 
for 0; production by fMLP but not by PMA or OAG, 
indicating that tyrosine phosphorylation is required to 
activate PKC upon the receptor-dependent s imulation. 
This is based on the following observations: (i) the 0; 
production by fMLP and vanadate, but not by PMA 
and OAG, was inhibited by an inhibitor of tyrosine 
kinase, ST-638 (Fig. 2) (ii) the 0; production by fMLP, 
vanadate, PMA and OAG was inhibited by PKC inhib- 
itors such as calphostin C (Table I) and staurosporine 
(results not shown). Furthermore, the present study 
suggests that tyrosine phosphorylation is required at a 
step before DAG formation by PLC because the 0; 
production by fMLP and vanadate, but not by PMA 
and OAG, was inhibited by an inhibitor of PLC, neo- 
mycin (Fig. 1). The inhibition by neomycin seems to be 
due to the inhibition of phosphoinositide breakdown by 
PLC, because the inhibition by neomycin was remarka- 
bly restored by the addition of PIP, (Table II). The 
enzymes or proteins affected by the tyrosine phospho- 
rylation, however, could not be identified. A possible 
enzyme may be PLC because tyrosine phosphorylation 
of PI-PLCy enhances its activity [35,36] and mRNA for 
PLCy, is expressed in HL-60 cells [37,38], although sev- 
eral types of PLC exist in human neutrophils [3]. Gi,,, 
which is involved in PLC activation and is tyrosine- 
phosphorylated in activated neutrophils [5], may also be 
a candidate. Although it has been proposed that tyro- 
sine phosphorylation induces the activation of PLD [4] 
or of mitogen-activated protein kinase (MAP kinase) 
[lo], PLD was not involved in the signaling pathway 
under our experimental conditions, and MAP kinase 
has been supposed to be located at the downstream of 
PLC [IO]. The involvement of tyrosine phosphorylation 
on phosphatidylinositol 3-kinase (PI 3-kinase) is un- 
likely because PI 3-kinase in neutrophils is stimulated 
by fMLP without tyrosine phosphorylation [39]. 
The signaling pathway of neutrophils might be mod- 
ified by the procedure of the electropermeabilization 
because of the following reasons. First, staurosporine 
inhibited the 0; production of intact neutrophils stimu- 
lated by fMLP far less than that by OAG and PMA 
(results not shown), indicating that the production by 
fMLP was partially mediated by the PKC-independent 
pathway in accordance with previous reports [ 15,16,40], 
whereas the production by permeabilized cells stimu- 
lated by fMLP, OAG and PMA was inhibited by stau- 
rosporine in a similar dose-dependent manner. Thus, 
the PKC-independent pathway seems to be activated by 
fMLP in intact cells but not in permeabilized cells. Sec- 
ond, 1% ethanol caused about 80% inhibition of the 
fMLP-induced 0; production with or without cytocha- 
lasin B, and about 40% inhibition of the OAG- or PMA- 
induced 0; production in intact cells (results not 
shown). These results are compatible with a hypothesis 
that fMLP and PMA activate PLD [ 1 S-231, and that the 
PLD-mediated breakdown of phospholipids is induced 
by fMLP even in the absence of cytochalasin B [24]. 
Table I, however, showed that the production by the 
permeabilized cells stimulated by fMLP, OAG or PMA 
was not affected by 1% ethanol. The discrepancy of the 
effects of ethanol between the intact and permeabilized 
cells may be due to differences in the intracellular free 
Ca” concentrations. The concentration in permeabil- 
ized cells was essentially fixed to the physiological con- 
centration at a resting stage of neutrophils, 100 nM, and 
the activation of PLD is strictly Ca”-dependent and 
requires the increase in the intracellular free Ca2’ con- 
centration to about 1 PM [23]. 
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